Literature DB >> 13843228

Thalassaemia in a Gurkha family.

D J WEATHERALL, F VELLA.   

Abstract

Keywords:  ANEMIA, ERYTHROBLASTIC/genetics

Mesh:

Year:  1960        PMID: 13843228      PMCID: PMC1967709          DOI: 10.1136/bmj.1.5187.1711

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


× No keyword cloud information.
  5 in total

1.  Observations on the minor basic hemoglobin component in the blood of normal individuals and patients with thalassemia.

Authors:  H G KUNKEL; R CEPPELLINI; U MULLER-EBERHARD; J WOLF
Journal:  J Clin Invest       Date:  1957-11       Impact factor: 14.808

2.  Haemoglobin-H trait in a Nepalese Gurkha woman.

Authors:  M C BRAIN; F VELLA
Journal:  Lancet       Date:  1958-01-25       Impact factor: 79.321

3.  [Description of a new variety of congenital hemolytic anemia; hematologic study, electrophoretic and genetic].

Authors:  A GOUTTAS; P FESSAS; H TSEVRENIS; E XEFTERI
Journal:  Sang       Date:  1955

4.  Clinical states associated with alterations of the hemoglobin molecule; the Minot lecture.

Authors:  H A ITANO
Journal:  AMA Arch Intern Med       Date:  1955-09

5.  Studies on abnormal hemoglobins. I. Their demonstration in sickle cell anemia and other hematologic disorders by means of alkali denaturation.

Authors:  K SINGER; A I CHERNOFF; L SINGER
Journal:  Blood       Date:  1951-05       Impact factor: 22.113

  5 in total
  4 in total

1.  Rate of synthesis of haemoglobin A2 in thalassaemia.

Authors:  F Schettini; G Di Bitonto; A Mautone
Journal:  Z Kinderheilkd       Date:  1971

2.  beta+-Thalassemia intermedia with low HbF.

Authors:  M A Zago; F F Costa; C Bottura
Journal:  Klin Wochenschr       Date:  1983-01-17

Review 3.  Haemoglobinopathies, glucose-6-phosphate dehydrogenase deficiency and allied problems in the Indian subcontinent.

Authors:  J B Chatterjea
Journal:  Bull World Health Organ       Date:  1966       Impact factor: 9.408

Review 4.  A journey in science: early lessons from the hemoglobin field.

Authors:  David J Weatherall
Journal:  Mol Med       Date:  2014-11-11       Impact factor: 6.354

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.